Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 09, 2020

SELL
$85.91 - $100.83 $104 Million - $123 Million
-1,215,146 Closed
0 $0
Q2 2020

Aug 11, 2020

BUY
$73.37 - $98.18 $89.2 Million - $119 Million
1,215,146 New
1,215,146 $119 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Newport Trust CO Portfolio

Follow Newport Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Newport Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Newport Trust CO with notifications on news.